Poster presentation at Antibody Engineering and Therapeutics Asia 2025
Oct 10,2025
Dr. Shoji Ohuchi, CEO, CSO, and CTO of iBody will present a poster at Antibody Engineering & Therapeutics Asia 2025, to be held in Kyoto on October 20-22.
Efficient Generation of Monoclonal Antibodies to Small Molecules by Combining Optimal Antigen Design, Single-Cell Method, and Cell-Free Antibody Expression.
Ohuchi, S., Yamauchi, T., Uekusa, K., Suzuki, D., Yamada, T., Kao, K.C., Masaki Y., Seio, K.
iBody Inc, Institute of Science Tokyo
